Mereo BioPharma Group Plc (MREO)
Mereo BioPharma Group Market Cap : 63.20M for March 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 0.8472M |
| NuCana Plc | 8.948M |
| Autolus Therapeutics Plc | 444.46M |
| Bicycle Therapeutics Plc | 397.48M |
| AstraZeneca PLC | 315.84B |
Market Cap Related Metrics
| PS Ratio | 124.05 |
| PEG Ratio | -0.2482 |
| Price to Book Value | 1.356 |
| Price | 0.3975 |
| Earnings Yield | -66.31% |
| PEGY Ratio | -0.2482 |